Latest Facts and Figures


This is your quick reference guide to key facts, statistics and latest policy positions on the Biotech Industry. Please see below for topical information on Finance, Biofuels, Industrial, Agri-food, and Healthcare Biotechnology.

  • Modern biotechnology and its applications generate almost 2% of EU gross value added, indicating that its importance is comparable to Europe’s largest industry sectors.

  • The European dedicated biotechnology industry directly employs 96.500 people, mostly in SMEs; however given biotechnology’s “enabling effect”, employment in industries using biotechnology products is many times higher.

  • Revenues for biotech vaccines jumped from EUR 65 million in 1996 to EUR 259 million.

  • In the agro-industry, up to 20% of the input sector’s turnover is now related to biotech.

  • In industrial biotech the EU produces about 75% of the world’s enzymes.

From the EU's Bio4EU Study carried out by the Joint Research Centre (April 2007)

General Facts and Figures

Inventory and analysis of national public policies that stimulate biotechnology research, its exploitation and commercialisation by industry in Europe in the period 2002–2005
"The BioPolis Study"

Joint Research Centre Industry Scoreboard
"Monitoring Industrial Research: the 2007 EU Industrial R&D Investment Scoreboard"

DG Enterprise and Industry Study
“Competitiveness of the European biotechnology industry”

The Joint Research Council's Bio4EU Study - April 2007 
"The Biotechnology for Europe Study: Consequences, opportunities and challenges of modern biotechnology for Europe"

DG Enterprise and Industry Study-  April 2005
"Benchmarking of public biotechnology policy"

EU Commission's “Users guide to European regulation in Biotechnology”
 

Comparative study on biotech in Europe - Critical I comparative study for EuropaBio (May 2006)
Critical I 2006 study

Feasibility Study: A Pan-European Market for Technology Growth Companies
Full report of the MIT Study ('09/2004) - Summary.

EU/US Biotech Industry at a glance from Ernst & Young Report 2002

 

Homepage  |   Contact  |   EuropaBio © 2000-2010   |  EuropaBio aisbl - VAT BE0477.520.310